Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.
Jinquan CaiJinwei ZhangPengfei WuWeitong YangQile YeQun ChenYanhong LiuPublished in: Journal of neuro-oncology (2018)
LINC00152 acted as a tumor oncogene with prognostic value for patients with glioblastoma through LINC00152/miR-612/AKT2/NF-κB axis.